Physician Wealth Advisors’s Vanguard ESG US Stock ETF ESGV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$557K Buy
4,111
+44
+1% +$5.92K 0.06% 113
2026
Q2
$538K Sell
4,067
-112
-3% -$14.3K 0.06% 111
2026
Q1
$469K Sell
4,179
-476
-10% -$56.5K 0.07% 109
2025
Q4
$563K Buy
4,655
+924
+25% +$111K 0.08% 97
2025
Q3
$442K Sell
3,731
-77
-2% -$8.77K 0.06% 115
2025
Q2
$417K Buy
3,808
+57
+2% +$5.75K 0.07% 112
2025
Q1
$367K Sell
3,751
-88
-2% -$9.2K 0.06% 120
2024
Q4
$403K Sell
3,839
-142
-4% -$14.9K 0.07% 112
2024
Q3
$409K Sell
3,981
-65
-2% -$6.37K 0.07% 106
2024
Q2
$408K Buy
4,046
+158
+4% +$14.6K 0.08% 103
2024
Q1
$346K Sell
3,888
-49
-1% -$4.36K 0.07% 114
2023
Q4
$342K Buy
+3,937
New +$310K 0.08% 111

Other funds holding ESGV

Physician Wealth Advisors's ESGV Position: Q3 2026 in Review

Physician Wealth Advisors increased its Vanguard ESG US Stock ETF (ESGV) stake by 1.1% in Q3 2026, buying an estimated $5.92K and bringing the position to 4,111 shares worth $557K. The position accounts for 0.06% of the portfolio, ranked #113.

Physician Wealth Advisors first reported a position in ESGV in Q4 2023 and has held it in 12 quarters since. The position peaked at $563K in Q4 2025. 729 funds tracked by Wall St. Rank hold ESGV as of Q3 2026.

  • Physician Wealth Advisors held 4,111 shares of Vanguard ESG US Stock ETF worth $557K as of Q3 2026.
  • Physician Wealth Advisors bought 44 Vanguard ESG US Stock ETF shares in Q3 2026, an estimated $5.92K.
  • Vanguard ESG US Stock ETF made up 0.06% of Physician Wealth Advisors's portfolio in Q3 2026, its #113 holding.
  • Physician Wealth Advisors first reported a position in Vanguard ESG US Stock ETF in Q4 2023 and has held it in 12 quarters since.
  • Physician Wealth Advisors's Vanguard ESG US Stock ETF position peaked at $563K in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Vanguard ESG US Stock ETF as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.